Furthermore, as we chose the endpoint of the experimental investigation on day 5, when HUS development was shown to not have reached its maximum [61,64], we cannot exclude that HUS development in SphK2−/− mice is delayed and might occur at a later point in time. The gene discussed is SPHK2; the disease is hemolytic-uremic syndrome.